BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16279683)

  • 1. [Development of BMP-related drugs].
    Kawate H; Ohnaka K; Takayanagi R
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():463-6. PubMed ID: 16279683
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stimulation of bone formation by statins].
    Komatsu Y; Nakao K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():783-8. PubMed ID: 15035227
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoporosis and bone morphogenetic protein (BMP)].
    Higuchi C; Nakase T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():439-43. PubMed ID: 16279679
    [No Abstract]   [Full Text] [Related]  

  • 4. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.
    Ohnaka K; Shimoda S; Nawata H; Shimokawa H; Kaibuchi K; Iwamoto Y; Takayanagi R
    Biochem Biophys Res Commun; 2001 Sep; 287(2):337-42. PubMed ID: 11554731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of mevalonate pathway in osteogenic cells].
    Ishimi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
    Cruz AC; Gruber BL
    Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
    Yoneda T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
    [No Abstract]   [Full Text] [Related]  

  • 8. Statin-induced osteogenesis uses in orthodontics: a scientific review.
    Wong RW; Rabie AB
    World J Orthod; 2006; 7(1):35-40. PubMed ID: 16548304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-lowering drugs may boost bones.
    Vogel G
    Science; 1999 Dec; 286(5446):1825-6. PubMed ID: 10610568
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of statins as potential targets for bone formation.
    Garrett IR; Mundy GR
    Arthritis Res; 2002; 4(4):237-40. PubMed ID: 12106493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of bone formation in vitro and in rodents by statins.
    Mundy G; Garrett R; Harris S; Chan J; Chen D; Rossini G; Boyce B; Zhao M; Gutierrez G
    Science; 1999 Dec; 286(5446):1946-9. PubMed ID: 10583956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
    Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling.
    Zhao M; Qiao M; Harris SE; Chen D; Oyajobi BO; Mundy GR
    Mol Cell Biol; 2006 Aug; 26(16):6197-208. PubMed ID: 16880529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rho and Rho-kinase].
    Sato J; Iiri T
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():197-202. PubMed ID: 16897863
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of statins.
    Reynolds TM; Wierzbicki AS
    Lancet; 2000 Sep; 356(9236):1195. PubMed ID: 11030324
    [No Abstract]   [Full Text] [Related]  

  • 18. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
    Nifuji A; Miura N; Kato N; Kellermann O; Noda M
    J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
    Schlienger RG; Meier CR
    Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.